SHZ:002082

Wanbangde Pharmaceutical Holding Group Co., Ltd. · SHZ · Healthcare · CNY · FY for 2025

Figures on this page computed 2026-11-08 13:31 UTC

Last close

n/aCNY

Market data

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aNet margin
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
0.32Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
0.8%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed

Growth is the furthest below its sector's middle: 0.04 against 0.50 on the market's range.

Margins: n/aWe do not hold this figure for this company, so there is nothing to place.

All from 100

lens 2 of 9

Sales

12.2

2016-12-31 to 2025-12-31100 at the start12.2

Sales: 100.00 on 2016-12-31 to 12.17 on 2025-12-31, down 88%.

Profit

-285

2016-12-31 to 2025-12-31100 at the start-285

Profit: 100.00 on 2016-12-31 to -285.04 on 2025-12-31, down 385%.

Shares in issue

258

2016-12-31 to 2025-12-31100 at the start258

Shares in issue: 100.00 on 2016-12-31 to 258.32 on 2025-12-31, up 158%.

Sales is at 12, Profit is at -285, Shares in issue is at 258, against 100 in 2016.

Sales is at 12, Profit is at -285, Shares in issue is at 258, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 10012
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Profit, where the first year is 100-285
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Shares in issue, where the first year is 100258
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY